![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MVB12A mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:735220 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MVB12A mRNA | CTD | PMID:21215274, PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of MVB12A mRNA | CTD | PMID:21570461 | 3,4-methylenedioxymethamphetamine | increases expression | EXP | | 6480464 | N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of MVB12A mRNA | CTD | PMID:20188158 | 4-hydroxyphenyl retinamide | increases expression | EXP | | 6480464 | Fenretinide results in increased expression of MVB12A mRNA | CTD | PMID:28973697 | arsane | affects methylation | ISO | RGD:1604253 | 6480464 | Arsenic affects the methylation of MVB12A gene | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | RGD:1604253 | 6480464 | Arsenic affects the methylation of MVB12A gene | CTD | PMID:25304211 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzoapyrene results in increased expression of MVB12A mRNA | CTD | PMID:22228805 | benzo[a]pyrene | increases methylation | ISO | RGD:1604253 | 6480464 | Benzoapyrene results in increased methylation of MVB12A 3' UTR | CTD | PMID:27901495 | bisphenol A | increases expression | ISO | RGD:735220 | 6480464 | bisphenol A results in increased expression of MVB12A mRNA | CTD | PMID:25181051 | cadmium dichloride | decreases methylation | ISO | RGD:735220 | 6480464 | Cadmium Chloride results in decreased methylation of MVB12A promoter | CTD | PMID:22457795 | cobalt dichloride | decreases expression | ISO | RGD:1604253 | 6480464 | cobaltous chloride results in decreased expression of MVB12A mRNA | CTD | PMID:19320972 | copper(II) sulfate | increases expression | ISO | RGD:1604253 | 6480464 | Copper Sulfate results in increased expression of MVB12A mRNA | CTD | PMID:19549813 | cytarabine | decreases expression | ISO | RGD:1604253 | 6480464 | Cytarabine results in decreased expression of MVB12A mRNA | CTD | PMID:21198554 | dibutyl phthalate | increases expression | ISO | RGD:735220 | 6480464 | Dibutyl Phthalate results in increased expression of MVB12A mRNA | CTD | PMID:21266533 | disodium selenite | increases expression | ISO | RGD:1604253 | 6480464 | Sodium Selenite results in increased expression of MVB12A mRNA | CTD | PMID:18175754 | dorsomorphin | multiple interactions | ISO | RGD:1604253 | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | RGD:1604253 | 6480464 | Doxorubicin results in decreased expression of MVB12A mRNA | CTD | PMID:29803840 | entinostat | increases expression | ISO | RGD:1604253 | 6480464 | entinostat results in increased expression of MVB12A mRNA | CTD | PMID:27188386 | folic acid | multiple interactions | EXP | | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MVB12A mRNA | CTD | PMID:22206623 | methylmercury chloride | decreases expression | ISO | RGD:1604253 | 6480464 | methylmercuric chloride results in decreased expression of MVB12A mRNA | CTD | PMID:27188386 | nickel atom | increases expression | ISO | RGD:1604253 | 6480464 | Nickel results in increased expression of MVB12A mRNA | CTD | PMID:24768652, PMID:25583101 | panobinostat | multiple interactions | ISO | RGD:1604253 | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of MVB12A mRNA | CTD | PMID:27188386 | panobinostat | decreases expression | ISO | RGD:1604253 | 6480464 | panobinostat results in decreased expression of MVB12A mRNA | CTD | PMID:26272509 | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of MVB12A mRNA | CTD | PMID:17562736 | phenylmercury acetate | decreases expression | ISO | RGD:1604253 | 6480464 | Phenylmercuric Acetate results in decreased expression of MVB12A mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | RGD:1604253 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of MVB12A mRNA | CTD | PMID:27188386 | propanal | decreases expression | ISO | RGD:1604253 | 6480464 | propionaldehyde results in decreased expression of MVB12A mRNA | CTD | PMID:26079696 | SB 431542 | multiple interactions | ISO | RGD:1604253 | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... | CTD | PMID:27188386 | tetrachloroethene | decreases expression | EXP | | 6480464 | Tetrachloroethylene results in decreased expression of MVB12A mRNA | CTD | PMID:28973375 | thapsigargin | decreases expression | EXP | | 6480464 | Thapsigargin results in decreased expression of MVB12A protein | CTD | PMID:24648495 | thimerosal | decreases expression | ISO | RGD:1604253 | 6480464 | Thimerosal results in decreased expression of MVB12A mRNA | CTD | PMID:27188386 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of MVB12A mRNA | CTD | PMID:17963808 | valproic acid | affects expression | ISO | RGD:1604253 | 6480464 | Valproic Acid affects the expression of MVB12A mRNA | CTD | PMID:25979313 | valproic acid | increases expression | ISO | RGD:1604253 | 6480464 | Valproic Acid results in increased expression of MVB12A mRNA | CTD | PMID:23179753, PMID:27188386 | |